Suspension of trading

Income Statement Amedisys

Stocks

AMED

US0234361089

Market Closed - Nasdaq 01:30:00 15/08/2025 am IST			5-day change	1st Jan Change
100.99 ^USD	+0.01%		-.--%	-

29/04	SnapMedTech, Inc. acquired connectRN Inc.	CI
01/25/01	Cornerstone Healthcare, Inc. and Tensaw River Healthcare LLC completed the acquisition of Equity Interests and Assets of Subsidiaries of UnitedHealth Group Incorporated, Amedisys, Inc. and certain other sellers.	CI

d30188d3d9330b75ce1fce6b1df42d0._mqcha8ybnQDLYsBIcTDqvprP7-uumZEHS098Tm3bms.lUfMvPAFFCZ3buJ4Q6W1ybQnZe7B0AgXbFxfoG_hPijOA67nlnQGAWIbyg

Published financial data: AMEDISYS

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Revenues	207.15Cr	221.41Cr	222.32Cr	223.64Cr	234.83Cr
Total Revenues	207.15Cr	221.41Cr	222.32Cr	223.64Cr	234.83Cr
Cost of Goods Sold, Total	161.08Cr	122.04Cr	126.04Cr	124.55Cr	133.06Cr
Gross Profit	46Cr	99Cr	96Cr	99Cr	101.77Cr
Selling General & Admin Expenses, Total	22Cr	71Cr	75Cr	78Cr	79Cr
Depreciation & Amortization - (IS)	2.88Cr	3.09Cr	2.49Cr	1.77Cr	1.8Cr
Other Operating Expenses, Total	25Cr	74Cr	78Cr	80Cr	81Cr
Operating Income	21Cr	25Cr	18Cr	19Cr	21Cr
Interest Expense, Total	-1.1Cr	-95.25L	-2.22Cr	-3.13Cr	-3.08Cr
Interest And Investment Income	3L	49T	2L	32.7L	81.1L
Net Interest Expenses	-1.07Cr	-94.76L	-2.2Cr	-2.8Cr	-2.27Cr
Income (Loss) On Equity Invest.	39.66L	3.6Cr	-45T	1.08Cr	62.67L
Other Non Operating Income (Expenses)	13.11L	17.45L	15.67L	64.73L	80.65L
EBT, Excl. Unusual Items	21Cr	28Cr	16Cr	18Cr	20Cr
Restructuring Charges	-50L	-	-	-	-
Merger & Related Restructuring Charges	-	-	-	-3.67Cr	-6.66Cr
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-29.8L	-	-30.09L	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-41.52L	-	-	-	-4.84Cr
Legal Settlements	-	-	-	-	-
Other Unusual Items	1.54Cr	3L	-	-11Cr	-
EBT, Incl. Unusual Items	21Cr	28Cr	16Cr	3.96Cr	8.62Cr
Income Tax Expense	2.56Cr	7.01Cr	4.25Cr	5.06Cr	4.81Cr
Earnings From Continuing Operations	19Cr	21Cr	12Cr	-1.09Cr	3.82Cr
Net Income to Company	19Cr	21Cr	12Cr	-1.09Cr	3.82Cr
Minority Interest	-15.76L	-10.94L	9L	11.89L	50.69L
Net Income - (IS)	18Cr	21Cr	12Cr	-97.47L	4.32Cr
Net Income to Common Incl Extra Items	18Cr	21Cr	12Cr	-97.47L	4.32Cr
Net Income to Common Excl. Extra Items	18Cr	21Cr	12Cr	-97.47L	4.32Cr
Per Share Items
Net EPS - Basic	5.64	6.4	3.65	-0.3	1.32
Basic EPS - Continuing Operations	5.64	6.4	3.65	-0.3	1.32
Basic Weighted Average Shares Outstanding	3.26Cr	3.26Cr	3.25Cr	3.26Cr	3.27Cr
Net EPS - Diluted	5.52	6.34	3.63	-0.3	1.31
Diluted EPS - Continuing Operations	5.52	6.34	3.63	-0.3	1.31
Diluted Weighted Average Shares Outstanding	3.33Cr	3.3Cr	3.27Cr	3.26Cr	3.31Cr
Normalized Basic EPS	3.94	5.33	3.17	3.53	4
Normalized Diluted EPS	3.85	5.27	3.15	3.53	3.96
Supplemental Items
EBITDA	24Cr	28Cr	21Cr	22Cr	24Cr
EBITA	23Cr	27Cr	20Cr	20Cr	21Cr
EBIT	21Cr	25Cr	18Cr	19Cr	21Cr
EBITDAR	28Cr	33Cr	26Cr	25Cr	27Cr
Effective Tax Rate - (Ratio)	12.16	25	26.55	127.6	55.74
Current Domestic Taxes	5.22Cr	2.55Cr	1.92Cr	2.99Cr	4.07Cr
Total Current Taxes	5.22Cr	2.55Cr	1.92Cr	2.99Cr	4.07Cr
Deferred Domestic Taxes	-2.66Cr	4.46Cr	2.33Cr	2.07Cr	74L
Deferred Foreign Taxes	-	-	-	-	-
Total Deferred Taxes	-2.66Cr	4.46Cr	2.33Cr	2.07Cr	74L
Normalized Net Income	13Cr	17Cr	10Cr	12Cr	13Cr
Interest on Long-Term Debt	1.1Cr	95.25L	2.22Cr	3.13Cr	3.08Cr
Supplemental Operating Expense Items
Advertising Expense	80L	74L	73L	72L	74L
General and Administrative Expenses	22Cr	24Cr	25Cr	26Cr	26Cr
Research And Development Expense From Footnotes	-	12L	30L	38L	45L
Net Rental Expense, Total	4.16Cr	4.36Cr	4.73Cr	3.75Cr	3.87Cr
Imputed Operating Lease Interest Expense	1.16Cr	77.93L	1.55Cr	1.83Cr	2.01Cr
Imputed Operating Lease Depreciation	3Cr	3.58Cr	3.18Cr	1.92Cr	1.86Cr
Stock-Based Comp., G&A Exp. (Total)	2.67Cr	2.39Cr	1.66Cr	2.61Cr	2.9Cr
Stock-Based Comp., Other (Total)	-	-	-	29.42L	16.11L
Total Stock-Based Compensation	2.67Cr	2.39Cr	1.66Cr	2.9Cr	3.06Cr

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Assets
Cash And Equivalents	8.18Cr	4.27Cr	4.05Cr	13Cr	30Cr
Total Cash And Short Term Investments	8.18Cr	4.27Cr	4.05Cr	13Cr	30Cr
Accounts Receivable, Total	26Cr	27Cr	30Cr	31Cr	30Cr
Other Receivables	25L	1.21Cr	1.24Cr	1.48Cr	1.02Cr
Total Receivables	26Cr	29Cr	31Cr	33Cr	31Cr
Prepaid Expenses	1.02Cr	1.04Cr	1.16Cr	1.46Cr	1.31Cr
Restricted Cash	15.49L	30.75L	1.36Cr	1.24Cr	-
Other Current Assets, Total	1.08Cr	1.35Cr	1.4Cr	1.53Cr	94.94L
Total Current Assets	36Cr	36Cr	39Cr	50Cr	63Cr
Gross Property Plant And Equipment	21Cr	22Cr	22Cr	22Cr	22Cr
Accumulated Depreciation	-9.5Cr	-9.69Cr	-10Cr	-9.24Cr	-10Cr
Net Property Plant And Equipment	12Cr	12Cr	12Cr	13Cr	12Cr
Long-term Investments	1.42Cr	5.31Cr	6.05Cr	6.61Cr	6.98Cr
Goodwill	93Cr	119.61Cr	128.74Cr	124.47Cr	121.39Cr
Other Intangibles, Total	7.42Cr	11Cr	10Cr	10Cr	8.12Cr
Deferred Tax Assets Long-Term	4.8Cr	3L	-	-	-
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	1.9Cr	1.99Cr	1.93Cr	1.9Cr	1.82Cr
Total Assets	156.72Cr	185.7Cr	197.62Cr	206.02Cr	213.87Cr
Liabilities
Accounts Payable, Total	4.27Cr	3.82Cr	4.37Cr	2.82Cr	4Cr
Accrued Expenses, Total	24Cr	23Cr	20Cr	33Cr	41Cr
Current Portion of Long-Term Debt	87.96L	1.21Cr	1.43Cr	2.25Cr	2.25Cr
Current Portion of Leases	3.17Cr	3.21Cr	3.47Cr	4.01Cr	4.14Cr
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	1.16Cr	-	-	-	-
Other Current Liabilities	13Cr	5.7Cr	6.32Cr	5.29Cr	-
Total Current Liabilities	46Cr	37Cr	36Cr	47Cr	51Cr
Long-Term Debt	20Cr	43Cr	42Cr	35Cr	33Cr
Long-Term Leases	6.29Cr	7Cr	7.06Cr	7.79Cr	7.01Cr
Deferred Tax Liability Non Current	-	-	2.04Cr	4.06Cr	4.81Cr
Other Non Current Liabilities	3.36Cr	49.79L	48.08L	14.18L	9L
Total Liabilities	76Cr	88Cr	87Cr	94Cr	96Cr
Common Stock, Total	38T	38T	38T	38T	38T
Additional Paid In Capital	70Cr	73Cr	76Cr	79Cr	82Cr
Retained Earnings	43Cr	64Cr	76Cr	75Cr	79Cr
Treasury Stock	-32Cr	-44Cr	-46Cr	-47Cr	-47Cr
Comprehensive Income and Other	-	-	-	-	-
Total Common Equity	81Cr	93Cr	105.16Cr	106.65Cr	113.45Cr
Minority Interest	15.17L	4.5Cr	5.5Cr	5.33Cr	4.54Cr
Total Equity	81Cr	98Cr	110.66Cr	111.98Cr	118Cr
Total Liabilities And Equity	156.72Cr	185.7Cr	197.62Cr	206.02Cr	213.87Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.28Cr	3.25Cr	3.26Cr	3.27Cr	3.84Cr
ECS Total Common Shares Outstanding	3.28Cr	3.25Cr	3.25Cr	3.27Cr	3.28Cr
Book Value / Share	24.66	28.65	32.34	32.65	34.61
Tangible Book Value	-20Cr	-38Cr	-34Cr	-28Cr	-16Cr
Tangible Book Value Per Share	-6.02	-11.56	-10.36	-8.6	-4.9
Total Debt	31Cr	55Cr	54Cr	49Cr	46Cr
Net Debt	23Cr	50Cr	50Cr	36Cr	16Cr
Debt Equivalent Oper. Leases	33Cr	35Cr	38Cr	30Cr	31Cr
Minority Interest, Total (Incl. Fin. Div)	15.17L	4.5Cr	5.5Cr	5.33Cr	4.54Cr
Equity Method Investments, Total	1.42Cr	5.31Cr	4.05Cr	4.61Cr	4.98Cr
Account Code - Inventory Valuation	3	3	3	3	3
Buildings, Total	90L	91L	97L	1.1Cr	-
Machinery, Total	5.31Cr	5.47Cr	5.69Cr	4Cr	7.86Cr
Full Time Employees	21T	21T	20T	19T	19T
Assets under Capital Lease - Gross	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Net Income	18Cr	21Cr	12Cr	-97.47L	4.32Cr
Depreciation & Amortization - CF	5.08Cr	5.27Cr	5.54Cr	5.19Cr	5.58Cr
Amortization of Goodwill and Intangible Assets - (CF)	1.66Cr	1.85Cr	1.35Cr	57L	47L
Depreciation & Amortization, Total	6.74Cr	7.12Cr	6.89Cr	5.76Cr	6.05Cr
Amortization of Deferred Charges, Total - (CF)	9L	9L	10L	10L	10L
(Gain) Loss From Sale Of Asset	-30T	-1L	5L	25.05L	-16.54L
(Gain) Loss on Sale of Investments - (CF)	29.8L	-3.11Cr	-	-	-
Asset Writedown & Restructuring Costs	46.52L	1L	51.09L	2L	4.84Cr
(Income) Loss On Equity Investments - (CF)	14.78L	4L	52.08L	-56.87L	-26.36L
Stock-Based Compensation (CF)	2.67Cr	2.38Cr	1.66Cr	2.9Cr	3.06Cr
Provision and Write-off of Bad Debts	-	-	-	-	-
Other Operating Activities, Total	-2.5Cr	4.57Cr	2.25Cr	13Cr	23.47L
Change In Accounts Receivable	21.14L	-1.8Cr	-1.42Cr	-2.67Cr	1.65Cr
Change In Accounts Payable	19.41L	-43.53L	48.94L	-1.58Cr	1.22Cr
Change in Other Net Operating Assets	2.22Cr	-11Cr	-9.57Cr	-2.07Cr	1.12Cr
Cash from Operations	29Cr	19Cr	13Cr	14Cr	22Cr
Capital Expenditure	-53.32L	-63.02L	-61.65L	-56.2L	-65.5L
Sale of Property, Plant, and Equipment	80T	1L	66T	1L	-
Cash Acquisitions	-30Cr	-27Cr	-7.2Cr	-4L	-
Divestitures	-	-	-	4.78Cr	-
Sale (Purchase) of Intangible assets	-	-4L	-10.5L	-70.93L	-8L
Investment in Marketable and Equity Securities, Total	1.7Cr	-52L	-1.56Cr	2L	-10.46L
Other Investing Activities, Total	1L	1L	3L	54T	55T
Cash from Investing	-29Cr	-28Cr	-9.45Cr	3.51Cr	-83.64L
Long-Term Debt Issued, Total	68Cr	79Cr	53Cr	2.3Cr	-
Total Debt Issued	68Cr	79Cr	53Cr	2.3Cr	-
Long-Term Debt Repaid, Total	-71Cr	-56Cr	-55Cr	-9.9Cr	-3.74Cr
Total Debt Repaid	-71Cr	-56Cr	-55Cr	-9.9Cr	-3.74Cr
Issuance of Common Stock	98.87L	60.22L	61.52L	27.02L	3L
Repurchase of Common Stock	-5.45Cr	-12Cr	-2.53Cr	-65.29L	-61.52L
Other Financing Activities, Total	5.89Cr	-6.43Cr	20.43L	-76.82L	-57.22L
Cash from Financing	-1.5Cr	5.51Cr	-3.04Cr	-8.75Cr	-4.89Cr
Net Change in Cash	-1.31Cr	-3.76Cr	83.64L	8.47Cr	16Cr
Supplemental Items
Cash Interest Paid	62.07L	52.91L	2.77Cr	2.98Cr	3Cr
Cash Income Tax Paid (Refund)	5.07Cr	3.41Cr	2.4Cr	2.91Cr	4.01Cr
Levered Free Cash Flow	38Cr	12Cr	12Cr	26Cr	28Cr
Unlevered Free Cash Flow	39Cr	13Cr	14Cr	28Cr	30Cr
Change In Net Working Capital	-17Cr	12Cr	5.8Cr	-8.25Cr	-8.1Cr
Net Debt Issued / Repaid	-2.92Cr	23Cr	-1.33Cr	-7.6Cr	-3.74Cr

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Profitability
Return on Assets	9.41	9.19	5.99	5.98	6.24
Return on Total Capital	12.77	11.91	7.26	7.42	8.07
Return On Equity %	25.5	23.52	11.3	-0.98	3.32
Return on Common Equity	25.33	24.02	11.96	-0.92	3.93
Margin Analysis
Gross Profit Margin %	22.24	44.88	43.31	44.31	43.34
SG&A Margin	10.56	32.12	33.92	34.88	33.65
EBITDA Margin %	11.68	12.76	9.39	9.7	10.03
EBITA Margin %	11.09	12.2	8.87	8.89	9.12
EBIT Margin %	10.28	11.36	8.27	8.63	8.92
Income From Continuing Operations Margin %	8.94	9.49	5.29	-0.49	1.62
Net Income Margin %	8.86	9.44	5.34	-0.44	1.84
Net Avail. For Common Margin %	8.86	9.44	5.34	-0.44	1.84
Normalized Net Income Margin	6.19	7.85	4.63	5.15	5.57
Levered Free Cash Flow Margin	18.47	5.47	5.5	11.56	11.82
Unlevered Free Cash Flow Margin	18.76	5.69	6.08	12.39	12.59
Asset Turnover
Asset Turnover	1.46	1.29	1.16	1.11	1.12
Fixed Assets Turnover	18.01	18.7	18.64	17.91	18.46
Receivables Turnover (Average Receivables)	8.41	8.35	7.78	7.33	7.71
Short Term Liquidity
Current Ratio	0.79	0.95	1.09	1.05	1.23
Quick Ratio	0.74	0.88	0.98	0.96	1.18
Operating Cash Flow to Current Liabilities	0.63	0.5	0.37	0.29	0.43
Days Sales Outstanding (Average Receivables)	43.53	43.69	46.93	49.79	47.49
Average Days Payable Outstanding	8.4	12.1	11.87	10.55	9.38
Long Term Solvency
Total Debt/Equity	37.87	55.88	48.61	43.51	38.92
Total Debt / Total Capital	27.47	35.85	32.71	30.32	28.02
LT Debt/Equity	32.87	51.35	44.18	37.92	33.51
Long-Term Debt / Total Capital	23.84	32.94	29.73	26.42	24.12
Total Liabilities / Total Assets	48.27	47.42	44.01	45.65	44.83
EBIT / Interest Expense	19.3	26.42	8.27	6.17	6.81
EBITDA / Interest Expense	25.68	34.24	11.52	8.13	8.92
(EBITDA - Capex) / Interest Expense	25.2	33.58	11.24	7.96	8.7
Total Debt / EBITDA	1.08	1.67	2.1	1.92	1.67
Net Debt / EBITDA	0.79	1.54	1.94	1.42	0.57
Total Debt / (EBITDA - Capex)	1.1	1.71	2.15	1.96	1.72
Net Debt / (EBITDA - Capex)	0.81	1.57	1.99	1.45	0.58
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	5.93	6.88	0.41	0.59	5.01
Gross Profit, 1 Yr. Growth %	12.14	9.79	-1.83	2.92	2.7
EBITDA, 1 Yr. Growth %	22.54	19.28	-22.56	3.93	8.62
EBITA, 1 Yr. Growth %	23.64	20.24	-23.27	0.75	7.8
EBIT, 1 Yr. Growth %	19.06	20.94	-22.98	5.05	8.55
Earnings From Cont. Operations, 1 Yr. Growth %	44.78	13.49	-44	-109.29	-448.96
Net Income, 1 Yr. Growth %	44.76	13.87	-43.27	-108.22	-543.53
Normalized Net Income, 1 Yr. Growth %	20.51	41.15	-37.89	11.83	13.66
Diluted EPS Before Extra, 1 Yr. Growth %	43.75	14.86	-42.74	-108.26	-536.67
Accounts Receivable, 1 Yr. Growth %	7.39	7.77	7.94	5.59	-5.52
Net Property, Plant and Equip., 1 Yr. Growth %	3.77	2.16	-0.68	10.01	-5.49
Total Assets, 1 Yr. Growth %	24.11	18.49	6.42	4.25	3.81
Tangible Book Value, 1 Yr. Growth %	138.71	90.21	-10.36	-16.66	-42.85
Common Equity, 1 Yr. Growth %	26.35	15.09	12.91	1.42	6.38
Cash From Operations, 1 Yr. Growth %	43.05	-34.63	-29.44	2.93	61.58
Capital Expenditures, 1 Yr. Growth %	-32.4	18.19	-2.17	-8.84	16.55
Levered Free Cash Flow, 1 Yr. Growth %	179.66	-68.11	8.33	111.63	7.31
Unlevered Free Cash Flow, 1 Yr. Growth %	168.01	-67.3	14.65	105.16	6.7
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	11.62	6.4	3.6	0.5	2.78
Gross Profit, 2 Yr. CAGR %	14.21	11.09	4.23	0.51	2.81
EBITDA, 2 Yr. CAGR %	19.84	19.64	-2.12	-10.29	6.25
EBITA, 2 Yr. CAGR %	21.66	22.86	2.15	-8.73	7.98
EBIT, 2 Yr. CAGR %	17.18	18.58	-1.4	-10.05	6.79
Earnings From Cont. Operations, 2 Yr. CAGR %	24.16	28.18	-20.28	-77.19	-43.06
Net Income, 2 Yr. CAGR %	24.03	28.39	-19.63	-78.41	-39.63
Normalized Net Income, 2 Yr. CAGR %	14.02	27.86	-3.83	-16.66	12.74
Diluted EPS Before Extra, 2 Yr. CAGR %	24.7	28.49	-18.91	-78.25	-39.93
Accounts Receivable, 2 Yr. CAGR %	16.2	7.58	7.85	6.76	-0.12
Net Property, Plant and Equip., 2 Yr. CAGR %	99.46	2.96	0.73	4.53	1.97
Total Assets, 2 Yr. CAGR %	47.83	21.27	12.29	5.33	4.03
Tangible Book Value, 2 Yr. CAGR %	35.3	113.08	30.58	-13.57	-30.99
Common Equity, 2 Yr. CAGR %	29.63	20.59	13.99	7.01	3.87
Cash From Operations, 2 Yr. CAGR %	13.71	-3.3	-32.08	-14.78	28.96
Capital Expenditures, 2 Yr. CAGR %	-9.83	-10.62	7.53	-5.57	3.08
Levered Free Cash Flow, 2 Yr. CAGR %	52.71	-6.24	-42.38	51.35	50.7
Unlevered Free Cash Flow, 2 Yr. CAGR %	52.15	-7.03	-39.91	53.3	47.96
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	11.08	10.02	4.37	2.59	1.98
Gross Profit, 3 Yr. CAGR %	14.74	41.17	6.13	3.79	1.24
EBITDA, 3 Yr. CAGR %	23.54	18.82	1.88	-0.14	-4.38
EBITA, 3 Yr. CAGR %	27.36	20.3	3.31	1.68	-3.52
EBIT, 3 Yr. CAGR %	24.22	17.49	0.89	0.7	-4.23
Earnings From Cont. Operations, 3 Yr. CAGR %	82.07	20.5	-2.73	-61.06	-43.37
Net Income, 3 Yr. CAGR %	82.31	20.55	-2.21	-62.42	-40.87
Normalized Net Income, 3 Yr. CAGR %	22.77	20.82	-1.08	1.13	-7.58
Diluted EPS Before Extra, 3 Yr. CAGR %	84.42	21.33	-1.86	-62.12	-40.88
Accounts Receivable, 3 Yr. CAGR %	8.24	13.32	7.7	7.09	2.5
Net Property, Plant and Equip., 3 Yr. CAGR %	55.56	59.59	1.73	3.74	1.08
Total Assets, 3 Yr. CAGR %	24.43	37.32	16.1	9.55	4.82
Tangible Book Value, 3 Yr. CAGR %	9.8	51.57	59.66	12.42	-24.7
Common Equity, 3 Yr. CAGR %	16.23	24.59	17.97	9.64	6.8
Cash From Operations, 3 Yr. CAGR %	39.81	-5.45	-12.94	-21.99	5.48
Capital Expenditures, 3 Yr. CAGR %	-20.74	-1.32	-7.89	1.77	1.29
Levered Free Cash Flow, 3 Yr. CAGR %	64	-9.65	-3.89	-11.1	34.96
Unlevered Free Cash Flow, 3 Yr. CAGR %	63.35	-9.11	-2.52	-9.52	35.86
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.34	9.3	8.03	6.11	3.73
Gross Profit, 5 Yr. CAGR %	12.02	29.03	25.85	22.91	4.79
EBITDA, 5 Yr. CAGR %	22.37	28.24	10.22	5.19	3.61
EBITA, 5 Yr. CAGR %	27.52	33.26	12.16	5.08	3.67
EBIT, 5 Yr. CAGR %	25.62	32.43	10.58	4.47	3.21
Earnings From Cont. Operations, 5 Yr. CAGR %	140.28	41.06	30.85	-38.08	-21.49
Net Income, 5 Yr. CAGR %	127.38	41.19	31.38	-39.41	-19.37
Normalized Net Income, 5 Yr. CAGR %	23.41	34.41	8.25	3.15	4.23
Diluted EPS Before Extra, 5 Yr. CAGR %	127.04	41.95	32.77	-38.99	-19.35
Accounts Receivable, 5 Yr. CAGR %	15.34	10.61	8.08	10.65	4.5
Net Property, Plant and Equip., 5 Yr. CAGR %	22.37	26.47	30.74	34.74	1.83
Total Assets, 5 Yr. CAGR %	18.11	20.4	19.43	23.5	11.11
Tangible Book Value, 5 Yr. CAGR %	13.73	24.74	17.68	21.07	14.15
Common Equity, 5 Yr. CAGR %	14.59	15.14	15.33	17.24	12.12
Cash From Operations, 5 Yr. CAGR %	21.8	24.85	4.74	-9.3	1.88
Capital Expenditures, 5 Yr. CAGR %	-24.29	-16.7	-10.45	-3.04	-3.65
Levered Free Cash Flow, 5 Yr. CAGR %	47.15	30.2	7.09	9.53	15.05
Unlevered Free Cash Flow, 5 Yr. CAGR %	45.93	29.34	8.67	10.55	15.19